Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

25.10.2021

2 Am J Respir Crit Care Med
2 Ann Intern Med
23 BMJ
1 Clin Chem
4 Clin Infect Dis
6 Int J Infect Dis
2 J Med Virol
3 J Travel Med
5 J Virol
1 JAMA
1 Lancet
1 Lancet Infect Dis
11 N Engl J Med
6 Nature
1 Radiology
3 Science
1 Travel Med Infect Dis



    Am J Respir Crit Care Med

  1. BLOOM CI, Cullinan P, Wedzicha JA
    Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.
    Am J Respir Crit Care Med. 2021 Oct 20. doi: 10.1164/rccm.202107-1704.
    >> Share

  2. DE BOER E, Petrache I, Goldstein NM, Olin JT, et al
    Decreased Fatty Oxidation and Altered Lactate Production During Exercise in Post-Acute COVID-19 Patients.
    Am J Respir Crit Care Med. 2021 Oct 19. doi: 10.1164/rccm.202108-1903.
    >> Share


    Ann Intern Med

  3. NOVAZZI F, Taborelli S, Baj A, Focosi D, et al
    Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.
    Ann Intern Med. 2021 Oct 19. doi: 10.7326/M21-3486.
    >> Share

  4. ASARE S, Majmundar A, Islami F, Bandi P, et al
    Changes in Cigarette Sales in the United States During the COVID-19 Pandemic.
    Ann Intern Med. 2021 Oct 19. doi: 10.7326/M21-3350.
    >> Share


    BMJ

  5. SHOLZBERG M, Tang GH, Rahhal H, AlHamzah M, et al
    Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
    BMJ. 2021;375:n2400.
    >> Share

  6. ABBAS-HANIF A, Modi N, Smith SK, Majeed A, et al
    Covid-19 treatments and vaccines must be evaluated in pregnancy.
    BMJ. 2021;375:n2377.
    >> Share

  7. CHIOLERO A
    Protecting the world from future pandemics: 3/11 is another day to remember.
    BMJ. 2021;375:n2490.
    >> Share

  8. PATEL K, Chapman R, Gill R, Richards J, et al
    Ensuring an equitable recovery for the NHS.
    BMJ. 2021;375:n2456.
    >> Share

  9. SALMON R
    Delta variant: what is the real risk of hospital admission?
    BMJ. 2021;375:n2461.
    >> Share

  10. MURAGE P, Batalha HR, Lino S, Sterniczuk K, et al
    From drug discovery to coronaviruses: why restoring natural habitats is good for human health.
    BMJ. 2021;375:n2329.
    >> Share

  11. PAVORD S, Hunt BJ, Horner D, Bewley S, et al
    Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
    BMJ. 2021;375:n2195.
    >> Share

  12. KEVERN AJ
    Covid grief: medical examiner's office could be central point of access for counselling and support services.
    BMJ. 2021;374:n2378.
    >> Share

  13. ARNOTT RA
    Covid grief has cracked us open: showing vulnerability can be a sign of strength.
    BMJ. 2021;374:n2372.
    >> Share

  14. MENDIS S
    Regional vaccine production is key to ensuring equity.
    BMJ. 2021;374:n2354.
    >> Share

  15. IACOBUCCI G
    Covid-19: People who take statins may be less likely to die, research suggests.
    BMJ. 2021;375:n2536.
    >> Share

  16. LIMB M
    Covid-19: Scientists report "unacceptable" abuse and threats after speaking out during pandemic.
    BMJ. 2021;375:n2528.
    >> Share

  17. GURDASANI D, McKee M
    The parliamentary committee report on covid-19 response.
    BMJ. 2021;375:n2530.
    >> Share

  18. RIMMER A
    Covid-19: Government faces legal challenge over "failure to protect care home residents".
    BMJ. 2021;375:n2560.
    >> Share

  19. SENTHILINGAM M
    Covid-19: Why Africa's pandemic is different.
    BMJ. 2021;375:n2512.
    >> Share

  20. TANNE JH
    Covid-19: US cases drop overall but increase among children.
    BMJ. 2021;375:n2558.
    >> Share

  21. IACOBUCCI G
    Covid-19: Ministers told to reveal names of companies in "VIP lane" for PPE contracts.
    BMJ. 2021;375:n2554.
    >> Share

  22. TAYLOR L
    Covid-19: Silencing health workers, researchers, and journalists caused unnecessary deaths, says Amnesty.
    BMJ. 2021;375:n2552.
    >> Share

  23. MAHASE E
    Covid-19: Prevalence rises among schoolchildren in England.
    BMJ. 2021;375:n2542.
    >> Share

  24. MAHASE E
    Covid-19: Valneva's vaccine produces stronger immune response than AstraZeneca's, company reports.
    BMJ. 2021;375:n2551.
    >> Share

  25. MAHASE E
    Covid-19: Northern Syria faces severe wave of infections, MSF warns.
    BMJ. 2021;375:n2543.
    >> Share

  26. KOTTA PA, Elango M
    A guide for final year medical students: transitioning to foundation training during the covid-19 pandemic.
    BMJ. 2021;375:n2287.
    >> Share

  27. TORJESEN I
    Covid-19: PCR testing is suspended at private laboratory after high rate of false negatives.
    BMJ. 2021;375:n2535.
    >> Share


    Clin Chem

  28. PECORA ND, Pettengill M
    The Role of Laboratory-Based Viral Testing in the COVID-19 Pandemic.
    Clin Chem. 2021 Oct 18. pii: 6400244. doi: 10.1093.
    >> Share


    Clin Infect Dis

  29. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  30. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    >> Share

  31. BROSSEAU LM, Escandon K, Ulrich AK, Rasmussen AL, et al
    SARS-CoV-2 Dose, Infection, and Disease Outcomes for COVID-19 - A Review.
    Clin Infect Dis. 2021 Oct 15. pii: 6397523. doi: 10.1093.
    >> Share

  32. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel.
    Clin Infect Dis. 2021 Oct 20. pii: 6398589. doi: 10.1093.
    >> Share


    Int J Infect Dis

  33. BRANDAO AAGS, de Oliveira CZ, Rojas SO, Ordinola AAM, et al
    Thromboembolic and bleeding events in ICU patients with COVID-19: results from a Brazilian tertiary hospital.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00812.
    >> Share

  34. JEONG J, Choi HS
    Sudden sensorineural hearing loss after COVID-19 vaccination.
    Int J Infect Dis. 2021 Oct 17. pii: S1201-9712(21)00815.
    >> Share

  35. BOZZI G, Lombardi A, Ludovisi S, Muscatello A, et al
    TRANSIENT INCREASE OF PLASMA HIV RNA AFTER COVID-19 VACCINATION WITH mRNA-1272.
    Int J Infect Dis. 2021 Oct 16. pii: S1201-9712(21)00806.
    >> Share

  36. HERIYANTO RS, Kurniawan A, Wijovi F, Halim DA, et al
    The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after sinovac vaccine administration on clinical year medical student in Indonesia.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00797.
    >> Share

  37. HASAN ZT, Atrakji DMQYMAA, Mehuaiden DAK
    The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00798.
    >> Share

  38. MASAI AN, Akin PL
    Practice of COVID-19 preventive measures and risk of acute respiratory infections: a longitudinal study in students from 95 countries.
    Int J Infect Dis. 2021 Oct 12. pii: S1201-9712(21)00803.
    >> Share


    J Med Virol

  39. KAYA H, Usuda D
    Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts.
    J Med Virol. 2021 Oct 18. doi: 10.1002/jmv.27401.
    >> Share

  40. D'ETTORRE G, Gentilini Cacciola E, Santinelli L, De Girolamo G, et al
    Covid-19 sequelae in working age patients: A systematic review.
    J Med Virol. 2021 Oct 16. doi: 10.1002/jmv.27399.
    >> Share


    J Travel Med

  41. GOBBI F, Noharet R, Abreu C, Del Mar Lago Nunez M, et al
    South Europe perspective of COVID-19 impact on travel medicine.
    J Travel Med. 2021 Oct 15. pii: 6398120. doi: 10.1093.
    >> Share

  42. LEE BU
    A high attack rate of 90% of SARS-CoV-2 Delta variant infections in crew personnel on a single navy ship.
    J Travel Med. 2021 Oct 20. pii: 6404468. doi: 10.1093.
    >> Share

  43. KANT R, Dwivedi G, Zaman K, Sahay RR, et al
    Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin.
    J Travel Med. 2021 Oct 15. pii: 6397775. doi: 10.1093.
    >> Share


    J Virol

  44. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    >> Share

  45. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    >> Share

  46. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    >> Share

  47. LUSVARGHI S, Wang W, Herrup R, Neerukonda SN, et al
    Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects.
    J Virol. 2021 Oct 20:JVI0111021. doi: 10.1128/JVI.01110.
    >> Share

  48. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    >> Share


    JAMA

  49. KUEHN BM
    COVID-19 Rolls Back Progress Against HIV, TB, and Malaria.
    JAMA. 2021;326:1471.
    >> Share


    Lancet

  50. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share


    Lancet Infect Dis

  51. THE LANCET INFECTIOUS DISEASES
    Unmet need for COVID-19 therapies in community settings.
    Lancet Infect Dis. 2021 Oct 14. pii: S1473-3099(21)00633.
    >> Share


    N Engl J Med

  52. MCARDLE AJ, Cunnington AJ, Levin M
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  53. MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
    Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
    >> Share

  54. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    >> Share

  55. TEMPLE C, Hoang R, Hendrickson RG
    Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114907.
    >> Share

  56. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
    >> Share

  57. SHEIKH A, Robertson C, Taylor B
    BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
    >> Share

  58. ESSEX R, Weldon SM
    Health Care Worker Strikes and the Covid Pandemic. Reply.
    N Engl J Med. 2021;385:e43.
    >> Share

  59. CHAN SSC
    Health Care Worker Strikes and the Covid Pandemic.
    N Engl J Med. 2021;385:e43.
    >> Share

  60. HARLEY JB
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share

  61. SON MBF, Newburger JW, Randolph AG
    Therapy for Multisystem Inflammatory Syndrome in Children. Reply.
    N Engl J Med. 2021;385:e42.
    >> Share

  62. OULDALI N, Belot A, Angoulvant F
    Therapy for Multisystem Inflammatory Syndrome in Children.
    N Engl J Med. 2021;385:e42.
    >> Share


    Nature

  63. MAXMEN A
    WHO names researchers to reboot outbreak origin investigations.
    Nature. 2021 Oct 14. pii: 10.1038/d41586-021-02813.
    >> Share

  64. ANDREANO E, Paciello I, Piccini G, Manganaro N, et al
    Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.
    Nature. 2021 Oct 20. pii: 10.1038/s41586-021-04117.
    >> Share

  65. BAKER N, Van Noorden R
    Coronapod: the COVID scientists facing violent threats.
    Nature. 2021 Oct 8. pii: 10.1038/d41586-021-02852.
    >> Share


  66. Scientists under attack and weird viruses - the week in infographics.
    Nature. 2021 Oct 15. pii: 10.1038/d41586-021-02817.
    >> Share

  67. CALLAWAY E
    COVID super-immunity: one of the pandemic's great puzzles.
    Nature. 2021;598:393-394.
    >> Share

  68. MALLAPATY S
    China's COVID vaccines have been crucial - now immunity is waning.
    Nature. 2021;598:398-399.
    >> Share


    Radiology

  69. LOWRY KP, Bissell M, Miglioretti DL, Kerlikowske K, et al
    Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
    Radiology. 2021 Oct 19:211808. doi: 10.1148/radiol.2021211808.
    >> Share


    Science

  70. KUPFERSCHMIDT K
    Pandemic enters transition phase-but to what?
    Science. 2021;374:135-136.
    >> Share

  71. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    >> Share

  72. YANNIER N, Hudson SE, Koedinger KR, Hirsh-Pasek K, et al
    Active learning: "Hands-on" meets "minds-on".
    Science. 2021;374:26-30.
    >> Share


    Travel Med Infect Dis

  73. PARAI D, Choudhary HR, Dash GC, Sahoo SK, et al
    Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection.
    Travel Med Infect Dis. 2021;44:102170.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016